PORTOLA Satellite Symposium
ADDRESSING THE CHALLENGE OF FACTOR XA INHIBITOR-RELATED CRITICAL BLEEDING   

20th May, 2019 13:45-14:45
Chairs: Pr. David Werring (London, UK) & Pr. Marc Maegele (Cologne, Germany)

13:45-14:01 DOAC-related Major Bleeding – Pivotal Clinical Trials/ Registries Informing ICH Management Needs.
Pr. Marc Maegele (Cologne, Germany)  

14:01-14:17 Novel Target FXa Inhibitor Antidote Therapeutic Options – Lessons from Phase-3 and ANNEXA-4 
Dr Mauricio Concha (Sarasota, FL, USA)

14:17-14:33 Case-Based Learning: Review of Challenging Patient Presentations 
Pr. Saskia Middeldorp (Amsterdam, NL)  
                                                   
14:33-14:45 Q&A Roundtable / Concluding Remarks     

                                                                                                                                                   
PENUMBRA - Artemis Device Symposium
NEW PERSPECTIVES: MINIMALLY INVASIVE HEMATOMA EVACUATION

20th May, 2019 18:40-19:50
Moderator: Dr. Jesús Lafuente, Hospital del Mar Barcelona, Spain

18:40-19:10 The Rationale behind the Minimally Invasive Hematoma Evacuation

Prof. Karin Klijn, Radboud UMC, Nijmegen, Netherlands

19:10-19:40 What Does the Surgical Evacuation with the Artemis Device Offer?
Dr. Nils Hecht, Charité Universitätsmedizin, Berlin, Germany

19:40-19:50 Questions and Answers

Keep Me Updated